When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

What’s unique about GLP-1s—a.k.a. Ozempic, Monjauro, Wegovy, and Zepbound, among others—is that they target hormones, which play a major role in your weight and weight loss, says Dr. Russo. These ...

Doctors Without Borders (MSF) and organisations representing people with diabetes picketed outside the offices of insulin ...

Novo Nordisk has long supplied human insulin pens to the national health department. But last year it decided not to bid for ...

Robert F. Kennedy Jr. has pledged to tackle high rates of chronic diseases such as diabetes and obesity as President-elect ...

Of 200 countries studied by experts by the World Health Organization, in the period between 1990 and 2022 - the most recent ...

From bespoke boob jobs and “luxury” dentists to award-winning skincare lines, here are the big names in eastern suburbs ...

When Sara first arrived at her rescuers’ home, she was sick, tired, and was covered in ringworms and signs of abuse all over ...

Sacking is too good for the 30 bishops who are being forced out of the Church of England over the revolting John Smyth ...

Doctors Without Borders and other organisations representing people with diabetes picketed outside the offices of insulin pen ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

The rise in type 2 diabetes cases globally presents opportunities for growth in the market for GLP-1 drugs like Ozempic and ...